Avatrombopag (Doptelet)

From HemOnc.org - A Hematology Oncology Wiki
(Redirected from Avatrombopag (E5501))
Jump to: navigation, search

Mechanism of action

Thrombopoietin receptor agonist

Diseases for which it is used

  1. Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Jun 19;123(25):3887-94. Epub 2014 May 6. link to original article PubMed

History of changes in FDA indication

Also known as

  • Code names: E5501, YM477, AKR 501
  • Brand name: Doptelet